Corporate Presentation

MediPharm Labs PORTERE CHTER PRIME Executing on International Growth First Move: Victoria, Australia expected operational H2 2019 pending licensing ● Gateway to Asia Pacific markets Short term: hub for import/export Long term: production facility Actively seeking import/export opportunities (where federally permissible) Construction is underway with launch expected H2 2019 1 hour south-east of Melbourne Manufacturing licence application submitted for review (Australian Office of Drug Control) Working with many cultivation partners Majority holder (80%) of subsidiary MediPharm Labs Australia Pty. Ltd. MediPharm Labs | 12

View entire presentation